| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,001 | 0,002 | 19:35 |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 12.01. | Polarean Highlights New CHEST Journal Study Demonstrating Xenon MRI Predicts Cystic Fibrosis Exacerbations | 3 | GlobeNewswire (USA) | ||
| 29.12.25 | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 29.12.2025 | 1.446 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 29.12.2025Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 29.12.2025ISIN NameAU0000111395 PROSPECH... ► Artikel lesen | |
| 24.12.25 | Polarean Imaging and OPG Power Ventures start trading on JP Jenkins | 6 | Alliance News | ||
| POLAREAN IMAGING Aktie jetzt für 0€ handeln | |||||
| 23.12.25 | XFRA 8ZF: AUSSETZUNG/SUSPENSION | 143 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILPOLAREAN IMAG.LS-... ► Artikel lesen | |
| 23.12.25 | AIM - Cancellation - Polarean Imaging Plc | 2 | RNS | ||
| 17.12.25 | FTSE Russell - Polarean Imaging: Constituent Deletion - Changes in FTSE UK Index Series | 2 | RNS | ||
| 15.12.25 | Polarean to delist from AIM following shareholder approval | 3 | Investing.com | ||
| 15.12.25 | Polarean Imaging: Aktionäre stimmen für Delisting vom AIM | 4 | Investing.com Deutsch | ||
| 15.12.25 | Polarean Imaging PLC - Result of General Meeting | 2 | RNS | ||
| 01.12.25 | Polarean: XENOVIEW 3T coil passes Philips compatibility testing | 1 | GlobeNewswire (USA) | ||
| 01.12.25 | Polarean: XENOVIEW-Brustspule mit Philips-MRT-Systemen kompatibel | 12 | Investing.com Deutsch | ||
| 01.12.25 | Polarean's chest coil compatible with Philips MRI systems | 3 | Investing.com | ||
| 01.12.25 | Polarean Imaging PLC - Chest coil passes Philips compatibility testing | 1 | RNS | ||
| 25.11.25 | Polarean Imaging PLC - First Xenon Hyperpolariser in Asia | - | RNS | ||
| 24.11.25 | IN BRIEF: Polarean Imaging signs exclusive Xenon distribution deal | 3 | Alliance News | ||
| 24.11.25 | Polarean: Korean distributor agreement with DK Healthcare in South Korea | 2 | GlobeNewswire (USA) | ||
| 24.11.25 | Polarean Imaging signs distribution deal in South Korea | 1 | Sharecast | ||
| 24.11.25 | Polarean Imaging PLC - Korean distributor agreement with DK Healthcare | - | RNS | ||
| 17.11.25 | Polarean Imaging plans AIM exit as seeks USD20 million funding | 2 | Alliance News | ||
| 14.11.25 | Polarean Imaging PLC - Proposed Cancellation of Admission & Notice of GM | - | RNS |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| MEDTRONIC | 83,06 | -0,43 % | Medtronic Receives FDA Clearance For MiniMed Go Smart MDI Diabetes App | WASHINGTON (dpa-AFX) - Medtronic (MDT), a medical device company, on Monday announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its MiniMed Go app. This... ► Artikel lesen | |
| HCA HEALTHCARE | 401,80 | -0,69 % | HCA Healthcare names Erica Rossitto as new chief nurse executive | ||
| LANTHEUS | 55,40 | +0,04 % | Lantheus Holdings, Inc.: Lantheus Announces Closing of SPECT Business Sale to SHINE Technologies | BEDFORD, Mass., Jan. 02, 2026 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. ("Lantheus" or the "Company") (NASDAQ: LNTH), the leading radiopharmaceutical-focused company dedicated to helping clinicians... ► Artikel lesen | |
| ENVISTA | 21,000 | -3,67 % | Envista Holdings Corporation: Envista Reports Third Quarter 2025 Results | BREA, Calif., Oct. 29, 2025 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) today announced results for the quarter ended September 26, 2025."This was another strong quarter... ► Artikel lesen | |
| CAREDX | 17,495 | +1,33 % | CareDx announces preliminary fourth quarter and full year 2025 financial results | ||
| GT BIOPHARMA | 0,746 | +2,16 % | GT Biopharma, Inc.: GT Biopharma Announces IND Submission for GTB-5550 TriKE, a B7-H3-targeted natural killer (NK) cell engager for B7-H3 expressing solid tumor cancers | GT Biopharma targets a portion of the estimated $362 billion global solid tumor market Preliminary, unaudited cash balance of approximately $7 million as of December 31, 2025 anticipated to extend... ► Artikel lesen | |
| SYNEOS HEALTH | - | - | Research Solutions, Inc.: Research Solutions Reports First Quarter Fiscal Year 2026 Results | Reports 21% Increase in ARR to $21.3 Million, Strong Growth in Net Income, Adjusted EBITDA and Operating Cash Flow
HENDERSON, Nev., Nov. 13, 2025 /PRNewswire/... ► Artikel lesen | |
| CARMAT | 0,099 | -100,00 % | CARMAT Provides an Update on the Ongoing Receivership Procedure | The Versailles Economic Court has opted for the takeover bid within the context of a sales plan submitted by CARMAT SAS and approved the sale plan1 of CARMAT SA to CARMAT SAS
Regulatory News:
CARMAT... ► Artikel lesen | |
| CHEMOMETEC | 93,70 | -2,04 % | Chemometec A/S: Growth in revenue and operating profit | Trading statement for Q1 2025/26 (1 July - 30 September 2025) Growth in revenue and operating profit Revenue was up by 8% in Q1 2025/26 (11% at constant exchange rates) to DKK 124.6 million from DKK... ► Artikel lesen | |
| ARRAIL GROUP | 0,203 | -100,00 % | XFRA I1D: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:
THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:
INSTRUMENT NAME Waehrung/Currency ISIN BIS/UNTIL
ARRAIL... ► Artikel lesen | |
| DEVYSER DIAGNOSTICS | 9,960 | +0,10 % | Devyser Diagnostics AB: Devyser secures a four-year tender in France for Devyser Compact | Devyser, a leading provider of advanced genetic testing solutions, has been awarded a new tender in Marseille, France, valued up to SEK 9.5 million over a 48-month period.
This tender with Assistance... ► Artikel lesen | |
| VENUS CONCEPT | 7,940 | +455,24 % | Venus Concept Stock Explodes Over 500% After Major Investor Takes Control | ||
| ALIGNMENT HEALTHCARE | 22,500 | 0,00 % | Alignment Healthcare Reports 31% Year-Over-Year Membership Growth to 275,300 as of Jan. 1, 2026 | Guides year-end 2026 health plan membership range of 290,000 to 296,000. Announces its expectation that consensus adjusted EBITDA of approximately $145 million in 2026 will be within its full-year... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 44,650 | -4,59 % | BERNSTEIN RESEARCH stuft Siemens Healthineers auf 'Outperform' | NEW YORK (dpa-AFX Analyser) - Das US-Analysehaus Bernstein Research hat die Einstufung für Siemens Healthineers auf "Outperform" mit einem Kursziel von 52,90 Euro belassen. 2025 sei ein schlechtes Jahr... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 37,100 | +0,46 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung gemäß Artikel 5 Abs. 1 lit. a) der Verordnung (EU) Nr. 596/2014 und Artikel 2 Abs. 1 der Delegierten... ► Artikel lesen |